>Any thoughts on how intense the competition might be from Schering's boceprevir?<
There’s been a lot already written on this—here and elsewhere. If you read the posts in question, I think you’ll be able to make an assessment. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”